Related Experiment Video
Updated: Aug 8, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy
Rossella E Nappi1, Francesca Ferdeghini, Patrizia Sampaolo
1Research Center for Reproductive Medicine, University of Pavia, Italy. renappi@tin.it
Maturitas
|May 30, 2006
Summary
Tibolone significantly improved clitoral blood flow and sexual function in postmenopausal women with female sexual dysfunction (FSD) compared to EPT. This hormone therapy enhanced libido and arousal, offering a better outcome for FSD symptoms.
Area of Science:
- Reproductive Endocrinology
- Women's Health
- Sexual Medicine
Background:
- Postmenopausal women frequently experience female sexual dysfunction (FSD), including libido and arousal disorders.
- Hormone therapy (HT) is used to manage menopausal symptoms, but its effects on clitoral hemodynamics and sexual function require further investigation.
Purpose of the Study:
- To evaluate the impact of tibolone versus estrogen-progestogen therapy (EPT) on clitoral erectile tissue hemodynamics in postmenopausal women with FSD.
- To assess changes in vaginal health and overall sexual function under different hormone therapies.
Main Methods:
- A pilot, randomized study involving 50 postmenopausal women with FSD.
- Participants received either tibolone or EPT for 6 months.
- Clitoral hemodynamic data were collected using duplex Doppler ultrasonography, alongside the Vaginal Health Index Score (VHIS) and the McCoy Female Sexuality Questionnaire (MFSQ).
Main Results:
- Tibolone significantly enhanced clitoral peak systolic and end diastolic velocities, indicating improved blood flow.
- Both tibolone and EPT improved vaginal health and alleviated atrophic states.
- Tibolone demonstrated a more pronounced and sustained improvement in sexual function scores compared to EPT over 6 months.
Conclusions:
- Tibolone therapy leads to significant improvements in clitoral circulation in postmenopausal women with FSD compared to EPT.
- Tibolone offers superior enhancement of sexual function, including libido and arousal, in this population.
